Dana Cohen for Personalized GLP-1 Treatments and Take Control of Your Weight Achieving meaningful weight loss with the latest medical advancements is within reach
Danish investigators compared GLP-1 receptor agonists with DPP-4 inhibitors, the US analysis compared semaglutide with other anti-obesity medications, and the Swedish study examined medication periods within a population already diagnosed with alcohol use disorder
Matsushita K, Coresh J, Sang Y, et al
Side effects like nausea and fatigue are common, expected responses to how the medication works
Nevertheless, although off-target inhibition of DPP-9 could be one potential explanation for the association between saxagliptin and heart failure in an experimental setting, it is uncertain whether mean exposure levels of saxagliptin reach a high enough level to affect DPP-9 activity when used at its therapeutic dose in humans
During the initial week, most patients experience gastrointestinal side effectsparticularly nausea and reduced appetiteas the body adjusts to the medication's effects on digestion and satiety